e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Cell biology of lung cancer and new biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative analysis of cisplatin treatment in in vitro 3D lung microtissue and monolayer cell cultures
Edit Kiss (Pécs, Hungary), Edit Kiss, Monika Avdicevic, David Ernszt, Judit E. Pongracz
Source:
International Congress 2015 – Cell biology of lung cancer and new biomarkers
Session:
Cell biology of lung cancer and new biomarkers
Session type:
Thematic Poster Session
Number:
4265
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Edit Kiss (Pécs, Hungary), Edit Kiss, Monika Avdicevic, David Ernszt, Judit E. Pongracz. Comparative analysis of cisplatin treatment in in vitro 3D lung microtissue and monolayer cell cultures. Eur Respir J 2015; 46: Suppl. 59, 4265
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Encapsulation of vinorelbine in polymeric nanoparticles improves efficacy in cancer cells and reduces inflammation in non-cancer cells
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Placenta-derived conditioned medium with anti-tumor properties on human NSCLC
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
Anti-cancer effects of bevacizumab and cisplatin on cancer cell invaded human ex-vivo lung tissue
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Antitumor efficacy of the double suicide genesin lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Aromatase inhibition alters the mechanical properties of non small-cell lung cancer cells affecting cell movement
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Exploring the volatome of different cancer cell lines
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Development of an invasive 3D lung tumor model for oncological research
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Molecular mechanisms of inhibition of lung cancer stem cells invasion by a novel soy isoflavone VF166
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
The active compound of garlic to treat non-small cell lung cancer:
in vitro studies
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept